Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis

OBJECTIVE: To describe the case histories of two patients who developed acquired haemophilia A following treatment with alemtuzumab for multiple sclerosis. RESULTS: Two patients, a 48-year-old woman and a 31-year-old woman, developed acquired haemophilia A 21 months after their second doses of alemt...

Descripción completa

Detalles Bibliográficos
Autores principales: Gounder, Kuhilan, Batt, Tracey, Dreyer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871705/
https://www.ncbi.nlm.nih.gov/pubmed/33681807
http://dx.doi.org/10.1136/bmjno-2020-000095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871705/
https://www.ncbi.nlm.nih.gov/pubmed/33681807
http://dx.doi.org/10.1136/bmjno-2020-000095

Ejemplares similares